Long-acting injectable ARVs are convenient and private, study participants report
New 'mini-pillbox' device could deliver three HIV drugs in a single once-weekly dose
Diabetes in people with HIV over 50 overwhelmingly linked to old antiretrovirals, not age or body weight
Dolutegravir and lamivudine potent and safe in people starting HIV therapy for the first time
Baseline CD4 count biggest factor in long-term immune system improvements after starting HIV therapy
HIV drug resistance now high enough to trigger a change in first-line treatment in eastern and southern Africa
European Cure Review concentrates on HIV therapeutic vaccines
HIV diagnoses in English gay men have been falling since 2014
